|
DYNLT3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
1.11022302462516E-15 |
| Normal-vs-Stage3 |
3.44169137633799E-15 |
| Normal-vs-Stage4 |
9.38500055447378E-10 |
| Stage1-vs-Stage2 |
4.121000E-01 |
| Stage1-vs-Stage3 |
7.514000E-01 |
| Stage1-vs-Stage4 |
7.027200E-01 |
| Stage2-vs-Stage3 |
2.454200E-01 |
| Stage2-vs-Stage4 |
8.898800E-01 |
| Stage3-vs-Stage4 |
5.010400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.55111512312578E-16 |
| Normal-vs-Asian |
7.89869999962001E-07 |
| Caucasian-vs-AfricanAmerican |
3.107400E-01 |
| Caucasian-vs-Asian |
6.407800E-01 |
| AfricanAmerican-vs-Asian |
8.438600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62581059726108E-12 |
| Male-vs-Female |
1.180340E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.606000E-04 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
<1E-12 |
| Normal-vs-Extreme_Obese |
2.801300E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.349590E-01 |
| Normal_Weight-vs-Obese |
3.472600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.406400E-01 |
| Extreme_Weight-vs-Obese |
3.717600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.454800E-01 |
| Obese-vs-Extreme_Obese |
8.734800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.90352203286193E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.29880567306873E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.194400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.507000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.303200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.774600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.775400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.950200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.31900000033269E-07 |
| Normal-VS-KIRP CIMP |
1.07500000001703E-06 |
| Normal-VS-Unclassified PRCC |
1.62447832963153E-12 |
| Type1 PRCC-VS-Type2 PRCC |
8.552300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.08610000000231E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.084000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.662000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.373400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.164400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
4.38538094726937E-14 |
| Normal-vs-N2 |
2.628400E-04 |
| N0-vs-N1 |
1.248830E-01 |
| N0-vs-N2 |
5.399200E-01 |
| N1-vs-N2 |
6.534400E-01 |
|
|
